Feasibility and Impact of 6-Month Rowing on Arm Lymphedema, Flexibility, and Fatigue in Breast Cancer Survivors
International Journal of Environmental Research and Public Health · 2025
DOI: 10.3390/ijerph22070987 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Environmental Research and Public Health, 2025. Verfasst von Ester Tommasini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Exercise & Sport Science Laboratory, Department of Psychology, Università Cattolica del Sacro Cuore, 20162 Milan, Italy. Hauptthemen laut MEDLINE: Breast Neoplasms, Fatigue, Lymphedema, Exercise Therapy. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Federazione Italiana Canottaggio, Sport e Salute SpA.
Abstract (Originalsprache)
Dragon boating and rowing are reported to be safe and provide physical benefits for women with breast cancer. Sculling, characterized by a distinct biomechanical technique, may serve as a potential tool to mitigate the adverse side effects of cancer treatments. This study investigated the feasibility and impact of a 6-month integrated physical activity program in breast cancer survivors. A longitudinal intervention study was conducted involving 20 women with breast cancer (age: 55.8 ± 6.1 yrs; BMI: 24.6 ± 3.3 kg/m2, stages I-III; surgery performed 6 months to 20 years prior) who participated in a 6-month exercise program consisting of three weekly one-hour sessions of adapted physical activity, walking, and sculling, with assessments conducted at baseline, 3 months, and 6 months. Physical activity, arm lymphedema, flexibility, and fatigue were tested. The program did not lead to the development or worsening of pre-existing lymphedema. A reduction of 78.9 cm3 was observed in the operated limb over 6 months (p = 0.005). An improvement in flexibility was also observed with a 2.7 cm increase in the back scratch test for the operated limb (p < 0.001). However, no significant change in fatigue-related variables was recorded. This is a novel study, as sculling has not previously been investigated in the context of breast cancer rehabilitation. The findings suggested that, when integrated into a structured exercise program, sculling is not only a safe and accessible activity but also effective in promoting physical and health-related improvements, with no adverse events reported. Therefore, it should be considered as part of a comprehensive rehabilitation plan for breast cancer survivors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Exercise & Sport Science Laboratory, Department of Psychology, Università Cattolica del Sacro Cuore, 20162 Milan, Italy.
- Senology Research Center, Department of Medicine and Innovation Technology (DiMIT), University of Insubria, 21100 Varese, Italy.
- Breast Unit, Azienda Socio Sanitaria Territoriale (ASST) Sette Laghi Hospital and University of Insubria, 21100 Varese, Italy.
ORCID-Profile: Ester Tommasini, Paolo Bruseghini, Christel Galvani
Förderung
- Federazione Italiana Canottaggio, Sport e Salute SpA
Zitieren
APA
Tommasini, E., Bruseghini, P., Rovera, F. A., Grande, A. M., & Galvani, C. (2025). Feasibility and Impact of 6-Month Rowing on Arm Lymphedema, Flexibility, and Fatigue in Breast Cancer Survivors. International Journal of Environmental Research and Public Health. https://doi.org/10.3390/ijerph22070987
Vancouver
Tommasini E, Bruseghini P, Rovera FA, Grande AM, Galvani C. Feasibility and Impact of 6-Month Rowing on Arm Lymphedema, Flexibility, and Fatigue in Breast Cancer Survivors. International Journal of Environmental Research and Public Health. 2025. doi:10.3390/ijerph22070987
BibTeX
@article{Tommasini2025,
author = {Tommasini, Ester and Bruseghini, Paolo and Rovera, Francesca Angela and Grande, Anna Maria and Galvani, Christel},
title = {Feasibility and Impact of 6-Month Rowing on Arm Lymphedema, Flexibility, and Fatigue in Breast Cancer Survivors},
journal = {International Journal of Environmental Research and Public Health},
year = {2025},
doi = {10.3390/ijerph22070987}
}
EUVIMED